Haematologica (May 2017)

The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation

  • Nicole Stadler,
  • Astrid Hasibeder,
  • Pamela Aranda Lopez,
  • Daniel Teschner,
  • Alexander Desuki,
  • Oliver Kriege,
  • Alexander N. R. Weber,
  • Christoph Schulz,
  • Christian Michel,
  • Georg Heβ,
  • Markus P. Radsak

DOI
https://doi.org/10.3324/haematol.2016.152017
Journal volume & issue
Vol. 102, no. 5

Abstract

Read online

No abstracts available.